SCHEMBL19699774

SCHEMBL19699774

Cc1cc(C(=O)O)c(N2CC3(COC3)C2)nc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 3/20 0.42
▸ ABCC1 P33527 1/20 0.36
▸ MBOAT4 Q96T53 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ OPRK1 P41145 2/20 0.34
▸ SCN10A Q9Y5Y9 1/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ MTOR P42345 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ KLKB1 P03952 1/20 0.34
▸ PIK3C3 Q8NEB9 1/20 0.33
▸ SYK P43405 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ KCNQ3 O43525 1/20 0.33
▸ KCNQ2 O43526 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ KIF18A Q8NI77 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20618190 0.87 ABCC1 (0.37) ABCC1OPRK1SCN10APIK3CDMTOR
SCHEMBL19699773 0.80 RBP4 (0.42) CHRM4MBOAT4SYKKCNQ3KCNQ2
SCHEMBL19699776 0.78 DHODH (0.39) CHRM4CYP1A2OPRK1SCN10ASYK
SCHEMBL12983811 0.74 GABRP (0.43) PIK3CDMTORPIK3CGPIK3C3KCNQ3
SCHEMBL19699783 0.74 CSNK2A2 (0.37) CHRM4SYK
SCHEMBL19699781 0.74 ROCK2 (0.35) CHRM4
SCHEMBL17478633 0.73 OPRK1 (0.50) OPRK1
SCHEMBL16824315 0.73 POLB (0.47) KCNQ3KCNQ2HPGD
SCHEMBL19699775 0.73 OPRK1 (0.37) CHRM4CYP1A2OPRK1SYKCNR2
SCHEMBL19699777 0.72 ADRA1A (0.35) CHRM4CYP1A2OPRK1SYKCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10189863-B2 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives PULMOCIDE LIMITED (GB) 2019-01-29 — — US disclosed
US-20170355717-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES PULMOCIDE LIMITED (GB) 2017-12-14 — — US disclosed
US-20170355717-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES PULMOCIDE LIMITED (GB) 2017-12-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189863-B2 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives AZI2, HRH4, ZC3HAV1 CHRM4 2658/4885ABCC1 2989/4885MBOAT4 2421/4885
US-20170355717-A1 NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES ZC3HAV1, DHX15, AZI2 CHRM4 2661/4885ABCC1 3124/4885MBOAT4 2597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback